Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment
出版年份 2021 全文链接
标题
Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-12-21
DOI
10.3389/fphar.2021.757120
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Trilaciclib: First Approval
- (2021) Sohita Dhillon DRUGS
- CDK1 couples proliferation with protein synthesis
- (2020) Katharina Haneke et al. JOURNAL OF CELL BIOLOGY
- CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis
- (2020) Jianxin Li et al. World Journal of Surgical Oncology
- Identification of Core Gene Expression Signature and Key Pathways in Colorectal Cancer
- (2020) Xiang Ding et al. Frontiers in Genetics
- Cdk4 and Cdk6 Couple the Cell-Cycle Machinery to Cell Growth via mTORC1
- (2020) Jesús Romero-Pozuelo et al. Cell Reports
- Telomere Stress Potentiates STING-Dependent Anti-tumor Immunity
- (2020) Ilgen Mender et al. CANCER CELL
- The Role of CDKs and CDKIs in Murine Development
- (2020) Grace Jean Campbell et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Cyclin-Dependent Kinase 1 in Translational Regulation in the M-Phase
- (2020) Jaroslav Kalous et al. Cells
- Signatures of co-deregulated genes and their transcriptional regulators in colorectal cancer
- (2020) Natalia Mastrogamvraki et al. npj Systems Biology and Applications
- Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large‐Scale Data to Inform Therapeutic Directions
- (2020) Denis L. Jardim et al. ONCOLOGIST
- The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor. A case report
- (2019) Kirsi Santti et al. ACTA ONCOLOGICA
- Discovery and characterization of SY-1365, a selective, covalent inhibitor of CDK7
- (2019) Shanhu Hu et al. CANCER RESEARCH
- Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein’s C-Terminal Helix
- (2019) Benjamin R. Topacio et al. MOLECULAR CELL
- P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy
- (2019) D.M. Fernández-Aroca et al. CANCER LETTERS
- Targeting CDK9 for treatment of colorectal cancer
- (2019) Muhammed H. Rahaman et al. Molecular Oncology
- Cyclin‑dependent kinase 9 expression and its association with CD8+ T cell infiltration in microsatellite‑stable colorectal cancer
- (2019) Jiefu Wang et al. Oncology Letters
- Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients
- (2019) Ruiz de Porras et al. Cancers
- Cell adhesion is regulated by CDK1 during the cell cycle
- (2018) Matthew C. Jones et al. JOURNAL OF CELL BIOLOGY
- ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment
- (2018) Hetal Patel et al. MOLECULAR CANCER THERAPEUTICS
- Prevention of Wogonin on Colorectal Cancer Tumorigenesis by Regulating p53 Nuclear Translocation
- (2018) Qian Feng et al. Frontiers in Pharmacology
- A Kinase-Independent Role for Cyclin-Dependent Kinase 19 in p53 Response
- (2017) K. Audrey Audetat et al. MOLECULAR AND CELLULAR BIOLOGY
- Targeting CDK1 and MEK/ERK Overcomes Apoptotic Resistance in BRAF-Mutant Human Colorectal Cancer
- (2017) Peng Zhang et al. MOLECULAR CANCER RESEARCH
- RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1
- (2017) S-H Chen et al. ONCOGENE
- Synthetic lethal interaction of CDK inhibition and autophagy inhibition in human solid cancer cell lines
- (2017) Yoshinari Okada et al. ONCOLOGY REPORTS
- Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy
- (2017) Caroline M. Robb et al. Oncotarget
- A map of protein dynamics during cell-cycle progression and cell-cycle exit
- (2017) Sara Gookin et al. PLOS BIOLOGY
- Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage
- (2017) Katarina Bačević et al. Scientific Reports
- Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer
- (2016) Yutaka Fujiwara et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cdk5 Directly Targets Nuclear p21 CIP1 and Promotes Cancer Cell Growth
- (2016) Pao-Hsuan Huang et al. CANCER RESEARCH
- Structure-Based Optimization of Potent, Selective, and Orally Bioavailable CDK8 Inhibitors Discovered by High-Throughput Screening
- (2016) Paul Czodrowski et al. JOURNAL OF MEDICINAL CHEMISTRY
- The cell fate: senescence or quiescence
- (2016) Menderes Yusuf Terzi et al. MOLECULAR BIOLOGY REPORTS
- A CDK2 activity signature predicts outcome in CDK2-low cancers
- (2016) S R McCurdy et al. ONCOGENE
- CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5–AP-1 axis
- (2016) Kangmin Zhuang et al. Cell Death & Disease
- Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors
- (2016) A. Patnaik et al. Cancer Discovery
- Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models
- (2016) Michael S. Lee et al. Oncotarget
- Cdk3-promoted epithelial-mesenchymal transition through activating AP-1 is involved in colorectal cancer metastasis
- (2016) Jinping Lu et al. Oncotarget
- Structural and Functional Analysis of the Cdk13/Cyclin K Complex
- (2016) Ann Katrin Greifenberg et al. Cell Reports
- Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy That Cotargets MEK and CDK4/6
- (2015) E. K. Ziemke et al. CLINICAL CANCER RESEARCH
- CCND1–CDK4–mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo
- (2015) Nicole Mende et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease
- (2015) Trevor Dale et al. Nature Chemical Biology
- Purvalanol induces endoplasmic reticulum stress-mediated apoptosis and autophagy in a time-dependent manner in HCT116 colon cancer cells
- (2015) AJDA COKER-GÜRKAN et al. ONCOLOGY REPORTS
- Expression and clinical significance of Sirt1 in colorectal cancer
- (2015) DENG-FENG YU et al. Oncology Letters
- High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients
- (2015) Wen-Wei Sung et al. BMC CANCER
- Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Modeling of the Antitumor Activity of LY2835219, a New Cyclin-Dependent Kinase 4/6 Inhibitor, in Mice Bearing Human Tumor Xenografts
- (2014) S. C. Tate et al. CLINICAL CANCER RESEARCH
- Inhibition of autophagy by 3-MA potentiates purvalanol-induced apoptosis in Bax deficient HCT 116 colon cancer cells
- (2014) Ajda Coker-Gurkan et al. EXPERIMENTAL CELL RESEARCH
- PD-0332991 induces G1 arrest of colorectal carcinoma cells through inhibition of the cyclin-dependent kinase-6 and retinoblastoma protein axis
- (2014) CHUNSHENG LI et al. Oncology Letters
- High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients
- (2014) Xiaojing Chen et al. Scientific Reports
- Inhibition of polyamine oxidase prevented cyclin-dependent kinase inhibitor-induced apoptosis in HCT 116 colon carcinoma cells
- (2013) Ajda Çoker Gürkan et al. APOPTOSIS
- Chemoprevention utility of silibinin and Cdk4 pathway inhibition in Apc −/+ ice
- (2013) Baktiar O Karim et al. BMC CANCER
- The Proliferation-Quiescence Decision Is Controlled by a Bifurcation in CDK2 Activity at Mitotic Exit
- (2013) Sabrina L. Spencer et al. CELL
- Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway
- (2013) Hu Wang et al. MOLECULAR CARCINOGENESIS
- Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells
- (2013) Licheng He et al. TOXICOLOGY
- Cyclin-dependent kinase 5 regulates E2F transcription factor through phosphorylation of Rb protein in neurons
- (2012) Akira Futatsugi et al. CELL CYCLE
- Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death
- (2012) K.-H. Chang et al. JOURNAL OF CELL SCIENCE
- Frequent Amplification of CENPF, GMNN and CDK13 Genes in Hepatocellular Carcinomas
- (2012) Hye-Eun Kim et al. PLoS One
- Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathways
- (2012) D. Horiuchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polyamine depletion enhances the roscovitine-induced apoptosis through the activation of mitochondria in HCT116 colon carcinoma cells
- (2011) Elif Damla Arısan et al. AMINO ACIDS
- Effects of cyclin-dependent kinase 8 specific siRNA on the proliferation and apoptosis of colon cancer cells
- (2011) Song-Bing He et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer
- (2011) D M Heijink et al. ONCOGENE
- Raman micro-spectroscopic analysis of cultured HCT116 colon cancer cells in the presence of roscovitine
- (2011) S. Akyuz et al. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
- The Prognostic Impact of p53 Expression on Sporadic Colorectal Cancer Is Dependent on p21 Status
- (2011) Martin Kruschewski et al. Cancers
- Increased angiogenesis inCdk4R24C/R24C:Apc+/Minintestinal tumors
- (2010) Zahidur R. Abedin et al. CELL CYCLE
- Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to Mitosis
- (2010) Olivier Gavet et al. DEVELOPMENTAL CELL
- Cyclin-dependent kinase 9–cyclin K functions in the replication stress response
- (2010) David S Yu et al. EMBO REPORTS
- PNUTS knockdown potentiates the apoptotic effect of Roscovitine in breast and colon cancer cells
- (2010) Krucher INTERNATIONAL JOURNAL OF ONCOLOGY
- Cdk5 Suppresses the Neuronal Cell Cycle by Disrupting the E2F1-DP1 Complex
- (2010) J. Zhang et al. JOURNAL OF NEUROSCIENCE
- Anti-tumor activity of noble indirubin derivatives in human solid tumor models In Vitro
- (2009) Soo-Hyun Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Chemoprevention of Mouse Intestinal Tumorigenesis by the Cyclin-Dependent Kinase Inhibitor SNS-032
- (2009) A. Boquoi et al. Cancer Prevention Research
- CDK8 expression in 470 colorectal cancers in relation to β-catenin activation, other molecular alterations and patient survival
- (2009) Ron Firestein et al. INTERNATIONAL JOURNAL OF CANCER
- Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines
- (2009) M. S. Squires et al. MOLECULAR CANCER THERAPEUTICS
- Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacy
- (2008) C. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- CDK8 is a colorectal cancer oncogene that regulates β-catenin activity
- (2008) Ron Firestein et al. NATURE
- Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly
- (2008) W A Braden et al. ONCOGENE
- Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells
- (2008) Mohamed Salah I Abaza et al. WORLD JOURNAL OF GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started